Paper39223142
The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma.
Liu YC and 5 others. Cell Death Discov, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma. Papers, record 39223142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39223142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30293904 | Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion. | Eur Urol | 2019 | https://conductscience.org/library/papers/30293904 | PubMed |
| 2 | 31866442 | A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. | Cell Metab | 2020 | https://conductscience.org/library/papers/31866442 | PubMed |
| 3 | 15175006 | Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter. | Biochem J | 2004 | https://conductscience.org/library/papers/15175006 | PubMed |
| 4 | 31819178 | ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. | Br J Cancer | 2020 | https://conductscience.org/library/papers/31819178 | PubMed |
| 5 | 31055111 | MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma. | Cancer Lett | 2019 | https://conductscience.org/library/papers/31055111 | PubMed |
| 6 | 36950604 | SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma. | Heliyon | 2023 | https://conductscience.org/library/papers/36950604 | PubMed |
| 7 | 38528565 | The upregulation of VGF enhances the progression of oral squamous carcinoma. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38528565 | PubMed |
| 8 | 28629361 | Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. | J Biomed Sci | 2017 | https://conductscience.org/library/papers/28629361 | PubMed |
| 9 | 28762332 | Long Noncoding RNA NEAT1 Promotes Proliferation and Invasion via Targeting miR-181a-5p in Non-Small Cell Lung Cancer. | Oncol Res | 2018 | https://conductscience.org/library/papers/28762332 | PubMed |
| 10 | 35419359 | SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic Adenocarcinoma. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35419359 | PubMed |
| 11 | 34630709 | Long non-coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA-204-5p/SEMA4B axis. | Oncol Lett | 2021 | https://conductscience.org/library/papers/34630709 | PubMed |
| 12 | 29100325 | Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo. | Oncotarget | 2017 | https://conductscience.org/library/papers/29100325 | PubMed |
| 13 | 33320840 | Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33320840 | PubMed |
| 14 | 25821004 | Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25821004 | PubMed |
| 15 | 27133077 | miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3K/Akt/mTOR pathway. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27133077 | PubMed |
| 16 | 30071532 | SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30071532 | PubMed |
| 17 | 30917872 | Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines. | Biol Res | 2019 | https://conductscience.org/library/papers/30917872 | PubMed |
| 18 | 36778122 | Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/36778122 | PubMed |
| 19 | 36289544 | LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/36289544 | PubMed |
| 20 | 30850586 | LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30850586 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42642776 | Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42642776 | PubMed |
| 42064548 | Cisplatin resistance in oral squamous cell carcinoma: mechanisms, reversal strategies, and emerging technologies. | Front Physiol | 2026 | https://conductscience.org/library/papers/42064548 | PubMed |
| 42005455 | Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis. | J Oral Biol Craniofac Res | 2026 | https://conductscience.org/library/papers/42005455 | PubMed |
| 41744616 | The Oncogenic Role of Long Non-Coding RNA NEAT1 in Head and Neck Squamous Cell Carcinoma: From Molecular Mechanisms to Clinical Implications. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41744616 | PubMed |
| 41606955 | Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression. | Cancer Biol Ther | 2026 | https://conductscience.org/library/papers/41606955 | PubMed |
| 41585138 | The roles of CD24-Sec14 like lipid binding 2 (SEC14L2) axis in the neoplastic progression of oral squamous cell carcinomas. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585138 | PubMed |
| 41585137 | Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) promotes tumor progression and predicts poor prognosis in oral squamous cell carcinoma. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585137 | PubMed |
| 41326881 | Crosstalk between miRNAs and oxidative stress: implications for cancer pathogenesis and therapy. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/41326881 | PubMed |
| 41326356 | Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41326356 | PubMed |
| 40444100 | Immune-metabolic crosstalk in HNSCC: mechanisms and therapeutic opportunities. | Front Oncol | 2025 | https://conductscience.org/library/papers/40444100 | PubMed |
| 40095205 | Research progress on ferroptosis in head and neck squamous cell carcinoma. | J Mol Histol | 2025 | https://conductscience.org/library/papers/40095205 | PubMed |
| 39766175 | Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39766175 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| MAP1LC3B | 81631 | PubTator's text mining | https://conductscience.org/library/genes/81631 | NCBI Gene |
| NEAT1 | 283131 | PubTator's text mining | https://conductscience.org/library/genes/283131 | NCBI Gene |
| SLC1A5 | 6510 | PubTator's text mining | https://conductscience.org/library/genes/6510 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39223142
GET https://conductscience.org/api/papers/v1/39223142/references?page=2